INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Tax withholdingVerified data

D'Silva Andrew J. reported OPRX

Chief Business Officer · OptimizeRx Corp · Common Stock

Side
F
Value
$15K
Shares
794
Price
$18.75
Executed
Oct 3, 2025
Disclosed
Nov 7, 2025
Disclosure timeline35 days from execution to publication · legal deadline 2 business days
Oct 3 executedNov 7, 2025 disclosed

OPRX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
19/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+1 / 25

$15K reported value · 1.7% of prior position

  • Filing timing+10 / 15

    Disclosed 25 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · OPRX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    19
    DJ
    D'Silva Andrew J.Chief Business Officer
    OPRXOptimizeRx Corp
    Tax withholding
    F$7,858
    414 sh
    Oct 1, 2025Nov 7, 2025
    traded Oct 1, 2025
    +37dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-25-050744
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 3, 2025
    Published
    Nov 7, 2025
    Ingested by INSIDER
    Nov 5, 04:34 UTC
    Last re-read
    Nov 5, 04:34 UTC

    Extracted facts

    Filer
    D'Silva Andrew J.
    Role
    Chief Business Officer
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    OptimizeRx Corp
    Ticker
    OPRX
    Shares
    794
    Price per share
    $18.75
    Value
    $14,888
    Execution date (reported)
    Oct 3, 2025
    Owned after transaction
    46.3K shares
    Days from execution to publication
    35

    Calculation

    Value = shares × reported price per share

    • Shares: 794
    • Price: $18.75

    = $14,888

    What this establishes

    D'Silva Andrew J. filed this Form 4 reporting a tax withholding of OPRX on Oct 3, 2025. It became public on Nov 7, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Business Officer
    D'Silva Andrew J.cik:0002083717
    Issuer
    OptimizeRx Corpcik:0001448431

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.